Steven A. McLaughlin, Cameron S. Crandall et Patrick E. McKinney, « Octreotide: an antidote for sulfonylurea-induced hypoglycemia », Annals of Emergency Medicine, vol. 36, no 2, , p. 133–138 (ISSN0196-0644, PMID10918104, DOI10.1067/mem.2000.108183, lire en ligne, consulté le )
issn.org
portal.issn.org
Steven A. McLaughlin, Cameron S. Crandall et Patrick E. McKinney, « Octreotide: an antidote for sulfonylurea-induced hypoglycemia », Annals of Emergency Medicine, vol. 36, no 2, , p. 133–138 (ISSN0196-0644, PMID10918104, DOI10.1067/mem.2000.108183, lire en ligne, consulté le )
nih.gov
ncbi.nlm.nih.gov
Steven A. McLaughlin, Cameron S. Crandall et Patrick E. McKinney, « Octreotide: an antidote for sulfonylurea-induced hypoglycemia », Annals of Emergency Medicine, vol. 36, no 2, , p. 133–138 (ISSN0196-0644, PMID10918104, DOI10.1067/mem.2000.108183, lire en ligne, consulté le )
(en) Zoungas S. et al., « Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. », N Engl J Med., vol. 371, no 15, , p. 1392-406 (PMID25234206)
pubmed.ncbi.nlm.nih.gov
Steven A. McLaughlin, Cameron S. Crandall et Patrick E. McKinney, « Octreotide: an antidote for sulfonylurea-induced hypoglycemia », Annals of Emergency Medicine, vol. 36, no 2, , p. 133–138 (ISSN0196-0644, PMID10918104, DOI10.1067/mem.2000.108183, lire en ligne, consulté le )
(en) Patel A. et al., « Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial », The Lancet, vol. 370, no 9590, , p. 829-840 (lire en ligne)
